Enhancing pneumococcal vaccine efficacy in pediatric patients with asthma: Investigating immune response modulation
Pneumococcal booster vaccination elicited a strong initial immune response and was associated with improved asthma outcomes. However, waning immunity highlights the need for further research into optimal vaccine scheduling, booster timing, and the influence of immune-modulating therapies in this high-risk pediatric population.
Authors
- Andrea Espina Rey (ORCID: https://orcid.org/0000-0002-9665-6885)
- Aledie Navas-Nazario (ORCID: https://orcid.org/0000-0002-1638-1894)
- Rebekah Brawley
Institutions
- University of Central Florida (US)
- College of Central Florida (US)
- Nemours Children's Health System (US)
- Nemours Children's Clinic (US)
- Florida College (US)
Publication Details
- Journal
- Journal of Asthma
- Published
- 2025-12-11
- DOI
- https://doi.org/10.1080/02770903.2025.2603328
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00